Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
cetuximab, capecitabine
DRUG
2 trials
Sponsors
Institute of Oncology Ljubljana
, Sun Yat-sen University
Conditions
Colorectal Cancer
Rectal Cancer
Phase 2
Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer
NCT00689702
Institute of Oncology Ljubljana
Rectal Cancer
Start: 2007-02-28
End: 2013-05-31
Updated: 2012-03-26
Phase 3
Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer
NCT04262635
Sun Yat-sen University
Colorectal Cancer
Start: 2021-09-24
End: 2024-08-30
Updated: 2023-08-02
Related Papers
Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for <i>RAS</i> Wild-Type Metastatic Colorectal Cancer
JAMA Network Open
2020-07-20
12 citations